Should You Stay Away From Unilever plc And Reckitt Benckiser Group Plc?

Are Unilever plc (LON: ULVR) and Reckitt Benckiser Group Plc (LON: RB) overpriced?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Unilever (LSE: ULVR) and Reckitt Benckiser (LSE: RB) are two of the most sought-after stocks trading in London today. 

Indeed, the two groups have outperformed the FTSE 100 by around 20% and 46% respectively over the past five years, and they now trade at a substantial premium to the wider market. 

Unilever currently trades at a rolling P/E of 25.1 and Reckitt trades at a rolling P/E of 25.3. The wider FTSE 100 trades at an average P/E of 15.5. 

The question is, should you avoid these two companies due to their high valuations?

An expensive bet

Due to their defensive nature, steady historic growth and cash generation, Reckitt and Unilever do deserve to trade at a premium to the wider market. 

However, based on historic valuations, Unilever and Reckitt appear to be overvalued at present. 

Take Unilever for example. During the past ten years, the company has traded at an average forward P/E of around 16, which isn’t overly demanding. But, over the past three years, the company’s valuation has steadily increased. Unilever now trades at a forward P/E of 21.7, a full 36% above the historic average. 

Similarly, Reckitt’s valuation has been pumped up since 2013. During the past decade, the company traded at an average forward P/E of around 17. The group is now trading at a forward P/E of 24.5. That’s a full 44% above the company’s historic average. 

Poor yield 

With valuations at ten-year highs, Unilever and Reckitt’s dividend yields also leave a lot to be desired. At present, Reckitt and Unilever both offer a yield below the market average.

Reckitt’s yield stands at 2.2%, and the payout is covered twice by earnings per share. Unilever currently supports a dividend yield of 2.4%, and the yield is covered 2.3 times by earnings per share.

According to City analysts, Unilever’s dividend yield is set to hit 3.3% next year, although the payout cover will fall to 1.5. The wider FTSE 100 yields 3.4% on average. 

Worth the premium? 

So, both Unilever and Reckitt look expensive at present levels compared to their historic valuations. Moreover, there could be trouble ahead for the two companies. 

You see, Unilever and Reckitt’s performance over the past few years has been driven by investors’ search for safety and yield.

As interest rates remain depressed, investors have been forced to push cash into higher yielding assets, to achieve a better return on their savings. 

A lot of this cash has been ploughed into relatively safe, defensive stocks like Unilever and Reckitt. And this has been the driving force behind the two companies’ recent performance. 

Coming to an end

Unfortunately, all good things come to an end.

Sooner or later, interest rates will start to move higher, and many analysts believe that when they do, defensive stocks like Unilever and Reckitt will suffer. 

With that in mind, it might be sensible to avoid Unilever and Reckitt for the time being until their valuations fall back to more normal levels.

The Motley Fool owns shares in Unilever.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »